High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains

被引:154
作者
Prunier, AL
Malbruny, B
Laurans, M
Brouard, J
Duhamel, JF
Leclercq, R
机构
[1] CHU Caen, Microbiol Serv, F-14033 Caen, France
[2] CHU Caen, Serv Pediat, F-14033 Caen, France
关键词
D O I
10.1086/374937
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Incidence of resistance to erythromycin at our institution reached 53% in 122 Staphylococcus aureus isolates obtained from patients with cystic fibrosis (CF) from 1997 to 1999. Macrolide-resistance genes were sought for in 20 erythromycin-resistant isolates from 9 patients with CF by use of polymerase chain reaction; 13 strains did not contain any known macrolide-resistance genes. Sequence of ribosomal genes rrl (23S rRNA), rplD (L4 protein), and rplV (L22 protein) revealed the presence of mutations in the target site of macrolides in 15 of the 20 isolates. A higher proportion of hypermutator strains was observed in a group of 89 CF staphylococcal isolates, compared with that in the 74 non-CF control isolates (13/89 vs. 1/74 with resistance to rifampin [P = .0045]; 9/89 vs. 1/74 with resistance to streptomycin [P = .04]). Various mutations or deletions of the mutator mutS gene were found not only in 5 of 11 hypermutable strains but also in 3 nonhypermutable strains harboring a large number of ribosomal mutations. The presence of a high proportion of hypermutable strains might explain the adaptation of certain strains in the patients, as well as the emergence of macrolide resistance as a result of antibiotic selective pressure in CF.
引用
收藏
页码:1709 / 1716
页数:8
相关论文
共 36 条
[1]   Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa [J].
Alonso, A ;
Campanario, E ;
Martínez, JL .
MICROBIOLOGY-SGM, 1999, 145 :2857-2862
[2]   Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus [J].
Aubry-Damon, H ;
Soussy, CJ ;
Courvalin, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2590-2594
[3]   Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: Roles of an infection control program and changes in aminoglycoside use [J].
AubryDamon, H ;
Legrand, P ;
BrunBuisson, C ;
Astier, A ;
Soussy, CJ ;
Leclercq, R .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :647-653
[4]   Genome and virulence determinants of high virulence community-acquired MRSA [J].
Baba, T ;
Takeuchi, F ;
Kuroda, M ;
Yuzawa, H ;
Aoki, K ;
Oguchi, A ;
Nagai, Y ;
Iwama, N ;
Asano, K ;
Naimi, T ;
Kuroda, H ;
Cui, L ;
Yamamoto, K ;
Hiramatsu, K .
LANCET, 2002, 359 (9320) :1819-1827
[5]   Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae [J].
Canu, A ;
Malbruny, B ;
Coquemont, M ;
Davies, TA ;
Appelbaum, PC ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :125-131
[6]  
*CASFM, 1996, CLIN MICROBIOL INFEC, V2, pS11
[7]  
Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257
[8]   DISTRIBUTION OF GENES ENCODING ERYTHROMYCIN RIBOSOMAL METHYLASES AND AN ERYTHROMYCIN EFFLUX PUMP IN EPIDEMIOLOGICALLY DISTINCT GROUPS OF STAPHYLOCOCCI [J].
EADY, EA ;
ROSS, JI ;
TIPPER, JL ;
WALTERS, CE ;
COVE, JH ;
NOBLE, WC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (02) :211-217
[9]  
ELPHICK HE, 2000, COCHRANE DATABASE SY, V1, DOI UNSP CD002007
[10]  
Fleiss JL, 1981, STAT METHODS RATES P